| A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma W Yang, Y Feng, J Zhou, OKW Cheung, J Cao, J Wang, W Tang, Y Tu, ... Science translational medicine 13 (588), eaaz6804, 2021 | 68 | 2021 |
| Jellyfish genomes reveal distinct homeobox gene clusters and conservation of small RNA processing W Nong, J Cao, Y Li, Z Qu, J Sun, T Swale, HY Yip, PY Qian, JW Qiu, ... Nature communications 11 (1), 3051, 2020 | 55 | 2020 |
| Horseshoe crab genomes reveal the evolution of genes and microRNAs after three rounds of whole genome duplication W Nong, Z Qu, Y Li, T Barton-Owen, AYP Wong, HY Yip, HT Lee, ... Communications Biology 4 (1), 83, 2021 | 39 | 2021 |
| Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma Z Xiong, SL Chan, J Zhou, JSL Vong, TT Kwong, X Zeng, H Wu, J Cao, ... Gut 72 (9), 1758-1773, 2023 | 26 | 2023 |
| The role of MicroRNAs in Drosophila regulation of insulin-like peptides and ecdysteroid signalling: where are we now? JQ Cao, WS Tong, YY Hiu, SS Tobe, WG Bendena, JHL Hui Advances in Insect Physiology 53, 55-85, 2017 | 10 | 2017 |
| PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma X Liu, M Liu, H Wu, W Tang, W Yang, TTH Chan, L Zhang, S Chen, ... JHEP Reports, 101087, 2024 | | 2024 |
| Lipid-mediated epigenetic activation of PPAR-gamma signaling promotes immune-checkpoint resistance in hepatocellular carcinoma Z Xiong, SL Chan, J Zhou, X Zeng, W Yang, H Wu, J Cao, JT Low, ... Cancer Research 84 (6_Supplement), 1426-1426, 2024 | | 2024 |
| Single-cell dissection of heterogeneity and dynamics of tumor ecosystem upon immune-checkpoint blockade in hepatocellular carcinoma ASL Cheng, Z Xiong, H Wu, J Cao, Z Liang, J Zhou, JJY Sung, K Yip, ... Cancer Research 84 (6_Supplement), 2534-2534, 2024 | | 2024 |
| Single-cell landscape of cancer-associated fibroblasts in immunotherapy resistance of hepatocellular carcinoma PPC Wong, J Cao, Z Xiong, H Wu, Q Cao, B Chen, KF To, SL Chan, ... Cancer Research 84 (6_Supplement), 6524-6524, 2024 | | 2024 |
| IDDF2023-ABS-0251 Epigenetic remodeling of endothelial cells underlying immune checkpoint resistance in hepatocellular carcinoma S Chen, X Liu, H Wu, P Wong, J Cao, Z Xiong, C Zhong Gut 72 (Suppl 1), A51-A51, 2023 | | 2023 |
| Tumor cell-macrophage crosstalk promotes immunotherapy resistance via lipid metabolism Z Liang, J Cao, W Tang, H Wu, Y Tu, Z Xiong, L Zhang, J Zhou, SL Chan, ... The Journal of Immunology 210 (1_Supplement), 169.02-169.02, 2023 | | 2023 |
| ICI efficacy information portal: a knowledgebase for responder prediction to immune checkpoint inhibitors J Chen, D Rebibo, J Cao, SYM Mok, N Patel, PC Tseng, Z Zhang, KY Yip NAR cancer 5 (1), zcad012, 2023 | | 2023 |
| IDDF2022-ABS-0195 Tumor cells-derived lipids modulate macrophage activity to regulate immunotherapy resistance of hepatocellular carcinoma Z Liang, J Cao, W Tang, H Wu, Y Tu, Z Xiong, J Zhou, SL Chan, ... Gut 71 (Suppl 2), A23-A24, 2022 | | 2022 |
| IDDF2021-ABS-0115 Enhancer dysregulation of myeloid-derived suppressor cells in hepatocellular carcinoma WY Law, SL Cheng, J Zhou, Z Xiong, J Cao Gut 70 (Suppl 2), A12-A12, 2021 | | 2021 |
| Immune-checkpoint therapy resistance by tumor-intrinsic evolution in hepatocellular carcinoma Z Xiong, J Zhou, J Cao, J Vong, X Zeng, Y Tu, Y Feng, A Cheng CANCER SCIENCE 112, 436-436, 2021 | | 2021 |
